Cite
HARVARD Citation
Deumelandt, K. et al. (2018). Synergy of vaccination and agonist OX40 treatment—toward a mechanism-driven combination of glioma immunotherapy. Neuro-oncology. 20 (1), pp. 4-5. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Deumelandt, K. et al. (2018). Synergy of vaccination and agonist OX40 treatment—toward a mechanism-driven combination of glioma immunotherapy. Neuro-oncology. 20 (1), pp. 4-5. [Online].